Frontier Capital Management Co. LLC Invests $4.20 Million in HealthEquity, Inc. (NASDAQ:HQY)

Frontier Capital Management Co. LLC acquired a new position in HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, Holdings Channel reports. The firm acquired 43,760 shares of the company’s stock, valued at approximately $4,199,000.

Several other large investors also recently added to or reduced their stakes in the business. Deutsche Bank AG increased its stake in HealthEquity by 25.9% in the 4th quarter. Deutsche Bank AG now owns 118,199 shares of the company’s stock worth $11,341,000 after acquiring an additional 24,289 shares during the last quarter. EP Wealth Advisors LLC grew its holdings in shares of HealthEquity by 9.7% during the fourth quarter. EP Wealth Advisors LLC now owns 4,555 shares of the company’s stock worth $437,000 after purchasing an additional 403 shares in the last quarter. Cetera Investment Advisers increased its position in shares of HealthEquity by 6.7% in the fourth quarter. Cetera Investment Advisers now owns 3,572 shares of the company’s stock worth $343,000 after purchasing an additional 225 shares during the last quarter. Brevan Howard Capital Management LP purchased a new stake in HealthEquity in the fourth quarter valued at approximately $200,000. Finally, Captrust Financial Advisors lifted its position in HealthEquity by 117.7% during the fourth quarter. Captrust Financial Advisors now owns 21,959 shares of the company’s stock valued at $2,107,000 after purchasing an additional 11,871 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HealthEquity stock opened at $90.44 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The business’s 50 day simple moving average is $88.05 and its two-hundred day simple moving average is $96.63. The stock has a market capitalization of $7.82 billion, a P/E ratio of 82.97, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45.

Analysts Set New Price Targets

A number of brokerages have recently commented on HQY. The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Barrington Research reissued an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Finally, KeyCorp decreased their price objective on HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $111.75.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now directly owns 84,969 shares of the company’s stock, valued at $6,597,842.85. This trade represents a 6.34 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the company’s stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares of the company’s stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 20,381 shares of company stock valued at $1,781,432 over the last three months. 2.20% of the stock is owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.